PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2010 | 5 | 1 | 62-64
Article title

Tuberculous bursitis of the wrist after anti-TNFalpha treatment: a case report

Content
Title variants
Languages of publication
EN
Abstracts
EN
In this report, we describe a case of tuberculous bursitis-osteomyelitis of the wrist, in an elderly patient with rheumatoid arthritis and anti-TNFalpha (anti-Tumor Necrosis Factor alpha) treatment.
Publisher

Journal
Year
Volume
5
Issue
1
Pages
62-64
Physical description
Dates
published
1 - 2 - 2010
online
29 - 1 - 2010
Contributors
  • Pathophysiology Department, Laikon General Hospital and Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece, nesavgust@yahoo.gr
  • Pathophysiology Department, Laikon General Hospital and Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece
  • 1st Department of Pathology, Laiko General Hospital, National and Kapodistrian University of Athens, 11527, Athens, Greece
  • Pathophysiology Department, Laikon General Hospital and Medical School, National and Kapodistrian University of Athens, 11527, Athens, Greece
References
  • [1] Dixon W.G., Watson K., Lunt M., Hyrich K.L., Silman A.J., Symmons D.P., Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis receiving antitumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register, Arthritis Rheum., 2006, 54, 2368–76 http://dx.doi.org/10.1002/art.21978[Crossref]
  • [2] Perez J.L., et. al., Impact of screening for latent tuberculosis prior to initiation anti-TNF therapy in North America and Europe. Ann Rheum Dis., 2005, 64, (Suppl III.), 86
  • [3] Winthrop K.L., Jeffrey N.S., Jereb J., Taylor Z., Iademarco M.F., Tuberculosis associated with therapy against tumor necrosis factor alpha. Arthritis Rheum., 2005, 52, 2968–2974 http://dx.doi.org/10.1002/art.21382[Crossref]
  • [4] American Thoracic Society., Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med., 2000, 161, 221–247
  • [5] Ehlers S., Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanrecept? Clin Infect Dis., 2005, 41 (Suppl 3.), 199–203 http://dx.doi.org/10.1086/429998[Crossref]
  • [6] Winthrop K.L., Yamashita S., Beekman S.E., Polgreen P.M., Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies; case finding through the emerging infections network. Clinical Infectious Disease., 2008, 46, 1738–40 http://dx.doi.org/10.1086/587989[Crossref]
  • [7] Sentruk N., Sahin S., Kocagoz T., Polymerase chain reaction in cutaneous tuberculosis: is it a reliable diagnostic method in paraffin-embedded tissue? Int J Dermatol., 2002, 41, 863–6 http://dx.doi.org/10.1046/j.1365-4362.2002.01604.x[Crossref]
  • [8] Pai M et. al., Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis., 2004, 4, 761–776 http://dx.doi.org/10.1016/S1473-3099(04)01206-X[Crossref]
  • [9] Nahid P., Pai M., Hopewell P.C., Advances in the diagnosis and treatment of tuberculosis. Am Thorac Soc., 2006, 3, 103–10 http://dx.doi.org/10.1513/pats.200511-119JH[Crossref]
  • [10] Jaovisidha S., Chen C., Ruy K.N., Siriwongpairat P., Pekanan P., Sartoris DJ., et. all., Tuberculous tenosynovitis and bursitis: imaging findings in 21 cases. Radiology., 1996, 201, 507–13 [PubMed]
  • [11] World Health Organization-third edition., 2003, Treatment of Tuberculosis, Guidelines for National Programmes. Treatment of extra pulmonary tuberculosis (4.10)
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_s11536-009-0078-6
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.